QINHUANGDAO ZIZHU PHARMACEUTICAL CO LTD
QINHUANGDAO ZIZHU PHARMACEUTICAL CO LTD (China) holds 6 active US FDA Type II Drug Master Files, has DMF or CEP filings on record for 10 active ingredients and is linked to 1 FDA-registered manufacturing site. 8 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “QINHUANGDAO ZIZHU PHARMACEUTICAL CO LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/qinhuangdao-zizhu-pharmaceutical-co-ltd
Overview
QINHUANGDAO ZIZHU PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 8 active FDA Type II Drug Master Files, covering CHORIONIC GONADOTROPIN; DIENOGEST (MICRONIZED); ESTRONE; GESTODENE (MICRONIZED); LEVONORGESTREL (MICRONIZED); MENOTROPINS.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which QINHUANGDAO ZIZHU PHARMACEUTICAL CO LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
QINHUANGDAO ZIZHU PHARMACEUTICAL CO LTD holds 6 active (6 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- GESTODENE (MICRONIZED)Active2015-06-08
- TIBOLONEActive2015-03-26
- DIENOGEST (MICRONIZED)Active2014-09-25
- ESTRONEActive2014-05-13
- LEVONORGESTREL (MICRONIZED)Active2013-10-20
- MIFEPRISTONEActive2011-01-30
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to QINHUANGDAO ZIZHU PHARMACEUTICAL CO LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
8 FDA enforcement records linked to this company.
- warning_letter2017-04-24
FDA Warning Letter (drug product)
- recall — Class II2017-04-19
cGMP Deviations; lack of quality assurance.
- recall — Class II2017-04-19
cGMP Deviations; lack of quality assurance.
- recall — Class II2017-04-19
cGMP Deviations; lack of quality assurance.
- recall — Class II2017-04-19
cGMP Deviations; lack of quality assurance.
- recall — Class II2017-04-19
cGMP Deviations; lack of quality assurance.
- recall — Class II2017-04-19
cGMP Deviations; lack of quality assurance.
- recall — Class II2017-04-19
cGMP Deviations; lack of quality assurance.
Is this QINHUANGDAO ZIZHU PHARMACEUTICAL CO LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.